Annual CFI
-$17.00 K
+$2.18 M+99.23%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual cash flow from investing activities is currently -$17.00 thousand, with the most recent change of +$2.18 million (+99.23%) on 31 December 2023. ZBIO annual CFI is now at all-time high.ZBIO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$26.76 M
-$26.73 M-76357.14%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly cash flow from investing activities is currently -$26.76 million, with the most recent change of -$26.73 million (-76357.14%) on 30 September 2024. Over the past year, it has dropped by -$26.74 million (-157311.76%).ZBIO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$26.83 M
-$26.76 M-36162.16%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology TTM cash flow from investing activities is currently -$26.83 million, with the most recent change of -$26.76 million (-36162.16%) on 30 September 2024. Over the past year, it has dropped by -$26.82 million (-157747.06%).ZBIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -10000.0% | -10000.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ZBIO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +99.2% | at low | at low | ||
| 5 y | 5 years | at high | +99.2% | at low | at low | ||
| alltime | all time | at high | +99.2% | <-9999.0% | at low | <-9999.0% | at low |
ProShares UltraPro Short Nasdaq Biotechnology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$26.76 M(>+9900.0%) | -$26.83 M(>+9900.0%) |
| June 2024 | - | -$35.00 K(+59.1%) | -$74.00 K(+89.7%) |
| Mar 2024 | - | -$22.00 K(+29.4%) | -$39.00 K(+129.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$17.00 K(-99.2%) | -$17.00 K(<-9900.0%) | -$17.00 K(<-9900.0%) |
| Sept 2023 | - | $0.00 | $0.00 |
| Dec 2022 | -$2.20 M | - | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual cash flow from investing activities?
- What is the all time high annual CFI for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly CFI year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM cash flow from investing activities?
- What is the all time high TTM CFI for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM CFI year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual cash flow from investing activities?
The current annual CFI of ZBIO is -$17.00 K
What is the all time high annual CFI for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual cash flow from investing activities is -$17.00 K
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly cash flow from investing activities?
The current quarterly CFI of ZBIO is -$26.76 M
What is the all time high quarterly CFI for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly cash flow from investing activities is $0.00
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly CFI year-on-year change?
Over the past year, ZBIO quarterly cash flow from investing activities has changed by -$26.74 M (-157311.76%)
What is ProShares UltraPro Short Nasdaq Biotechnology TTM cash flow from investing activities?
The current TTM CFI of ZBIO is -$26.83 M
What is the all time high TTM CFI for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high TTM cash flow from investing activities is $0.00
What is ProShares UltraPro Short Nasdaq Biotechnology TTM CFI year-on-year change?
Over the past year, ZBIO TTM cash flow from investing activities has changed by -$26.82 M (-157747.06%)